Sponsor:
Black Diamond Therapeutics, Inc.
Code:
NCT05256290
Conditions
Non-Small Cell Lung Cancer
Advanced Non-Small Cell Squamous Lung Cancer
Metastatic Lung Non-Small Cell Carcinoma
Metastatic Lung Cancer
NSCLC
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
silevertinib monotherapy
Brief summary:
Conditions
Non-Small Cell Lung Cancer
Advanced Non-Small Cell Squamous Lung Cancer
Metastatic Lung Non-Small Cell Carcinoma
Metastatic Lung Cancer
NSCLC
Study ID
NCT05256290
Start date
Mar 31, 2022
Status verified date
Jul, 2026
Completion date
Jun, 2028
Anticipated
Primary completion date
Mar, 2028
Anticipated
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Enrollment
220 participants
Anticipated
Allocation
Non randomized
Intervention Model
Sequential
Primary purpose
Treatment
Arms
experimental: Phase 1 Dose Escalation - Monotherapy (Recruitment Closed)
experimental: Phase 2 Cohort 1: NSCLC EGFR Non-Classical Driver Mutations (Recruitment Closed)
experimental: Phase 2 Cohort 2: NSCLC EGFR Acquired Resistance (C797S) Mutation (Recruitment Closed)
experimental: Phase 2 Cohort 3: Treatment Naive NSCLC EGFR Non-Classical Driver Mutations (Recruitment Closed)
experimental: Phase 2 Cohort 4: Treatment Naive NSCLC EGFR Non-Classical Driver Mutations at 150 mg QD Dose
Interventions
silevertinib monotherapy
Primary outcome measure
Central contacts
Locations
University of Alabama
Recruiting
Birmingham, Alabama, United States, 35294
Contacts
Banner MD Anderson Cancer Center
Recruiting
Gilbert, Arizona, United States, 85234
Contacts
City of Hope Orange County Lennar Foundation Cancer Center
Recruiting
Irvine, California, United States, 92618
Contacts
Diana Patterson
949-671-4763Cedars Sinai Medical Center
Recruiting
Los Angeles, California, United States, 90048
Contacts
Sibley Memorial Hospital Johns Hopkins Medicine
Recruiting
Washington D.C., District of Columbia, United States, 20016
Contacts
Mayo Clinic- Jacksonville
Recruiting
Jacksonville, Florida, United States, 32224
Contacts
Yanyan Lou
855-776-0015Miami Cancer Institute - Baptist Health South Florida
Recruiting
Miami, Florida, United States, 33176
Contacts
UHP- University of Hawaii Cancer Center
Recruiting
Honolulu, Hawaii, United States, 96813
Contacts
Evan Wu, MD
808-586-3010Robert H. Lurie Comprehensive Cancer Center at Northwestern University
Recruiting
Chicago, Illinois, United States, 60611
Contacts
Dana-Farber Cancer Institute
Recruiting
Boston, Massachusetts, United States, 02115
Contacts
Mayo Clinic- Rochester
Recruiting
Rochester, Minnesota, United States, 55905
Contacts
Anastasios Dimou, MD
855-776-0015Montefiore Medical Center
Recruiting
The Bronx, New York, United States, 10461
Contacts
University of Pittsburgh Medical Center - Hillman Cancer Center
Recruiting
Pittsburgh, Pennsylvania, United States, 15232
Contacts
Jennifer Ruth
ruthj2@upmc.eduTennessee Oncology
Recruiting
Nashville, Tennessee, United States, 37203
Contacts
Inova Schar Cancer Institute
Recruiting
Fairfax, Virginia, United States, 22031
Contacts
Next Oncology
Recruiting
Fairfax, Virginia, United States, 22031
Contacts
Rebecca Fisher
rfisher@nextoncology.comFred Hutchinson Cancer Center/University of Washington
Recruiting
Seattle, Washington, United States, 98109
Contacts
BC Cancer Vancouver
Recruiting
Vancouver, British Columbia, Canada, V5Z 4E6
Contacts
The Princess Margaret Cancer Centre
Recruiting
Toronto, Ontario, Canada, M5G 1X5
Contacts
Sponsor
Black Diamond Therapeutics, Inc.
Last update posted
Nov 18, 2026
Last verified
Jul, 2026
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-11-19. This information was provided to ClinicalTrials.gov by Black Diamond Therapeutics, Inc. on 2026-11-18. Recruitment status is synced daily from ClinicalTrials.gov and may not reflect the sponsor's current status. Confirm during your call.